BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12777207)

  • 1. Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation.
    Muñoz E; Gómez F; Paz JI; Casado I; Silva JM; Corcuera MT; Alonso MJ
    Eur J Histochem; 2003; 47(2):123-8. PubMed ID: 12777207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat.
    Xie W; Wong YC; Tsao SW
    Prostate; 2000 Jun; 44(1):31-9. PubMed ID: 10861755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of nuclear Ki-67 antigen in prostatic high grade intraepithelial neoplasia and prostatic carcinoma].
    Veliiković LJ; Dordević B; Rancić G; Marjanović G
    Vojnosanit Pregl; 2007 May; 64(5):325-30. PubMed ID: 17585548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The morphogenesis of cancer of the prostate (immunohistochemical research)].
    Vorobĭova LR
    Lik Sprava; 1998 May; (3):87-90. PubMed ID: 9695575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
    Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
    Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions.
    El Sharkawy SL; Abbas NF; Badawi MA; El Shaer MA
    J Clin Pathol; 2006 Nov; 59(11):1171-4. PubMed ID: 16574721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
    Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
    Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis.
    Di Silverio F; Gentile V; De Matteis A; Mariotti G; Giuseppe V; Luigi PA; Sciarra A
    Eur Urol; 2003 Feb; 43(2):164-75. PubMed ID: 12565775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of immunohistochemical expression of ERG and MAGI2 in prostatic carcinoma.
    Dawoud MM; Aiad HA; Bahbah AMNH; Shaban MI
    Ann Diagn Pathol; 2021 Jun; 52():151727. PubMed ID: 33713943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adhesion molecules and proliferation hyperplasic, pre neoplastic and neoplastic lesions in canine prostate.
    Rodrigues MM; Rema A; Gartner MF; Laufer-Amorim R
    Pak J Biol Sci; 2013 Nov; 16(21):1324-9. PubMed ID: 24511741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIAGNOSTIC UTILITY OF IMMUNOHISTOCHEMICAL EXPRESSION OF KI!67, P63 AND AMACR IN PROSTATE INTRAEPITHELIAL NEOPLASIA.
    Melnychuk MP
    Wiad Lek; 2023; 76(2):420-426. PubMed ID: 37010182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
    Wang W; Bergh A; Damber JE
    APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
    Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
    Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.